Huennekens R Scott — SEC insider filings
SEC reporting owner CIK 1365493. 29 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 29 filings on record, filed 2021-05-20 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 12,500 shares, $103,661 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 60,000 shares, $34,800 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 53.
- Largest priced transaction: purchase of 12,500 shares @ $8.29 ($103,661) in NeuroPace Inc, filed 2026-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NeuroPace Inc (NPCE) | Director | 4 | 1 leg · 12,500 sh · $103,661 | — | 4 |
| Acutus Medical, Inc. (AFIB) | Director | 4 | — | 1 leg · 60,000 sh · $34,800 | 6 |
| Hyperfine, Inc. (HYPR) | Director | 7 | — | — | 22 |
| NUVASIVE INC (NUVA) | Director | 4 | — | — | 9 |
| Envista Holdings Corp (NVST) | Director | 6 | — | — | 6 |
| QuidelOrtho Corp (QDEL) | Director | 4 | — | — | 6 |
Insider filings — Huennekens R Scott
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | NeuroPace Inc (NPCE) | Purchase (P): 12,500 @ $8.29 | EDGAR |
| 2026-06-29 | 4 | QuidelOrtho Corp (QDEL) | Grant/award (A): 15,532 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | NeuroPace Inc (NPCE) | Grant/award (A): 2,890 @ $0 · Grant/award (A): 5,368 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | QuidelOrtho Corp (QDEL) | Grant/award (A): 6,829 @ $0 · Option exercise (M): 6,829 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | Envista Holdings Corp (NVST) | Grant/award (A): 12,585 @ $0 | EDGAR |
| 2025-06-12 | 4 | Envista Holdings Corp (NVST) | Grant/award (A): 14,370 @ $0 | EDGAR |
| 2025-06-09 | 4 | NeuroPace Inc (NPCE) | Grant/award (A): 8,745 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | QuidelOrtho Corp (QDEL) | Grant/award (A): 6,829 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | QuidelOrtho Corp (QDEL) | Grant/award (A): 2,523 @ $0 · Option exercise (M): 2,523 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | NeuroPace Inc (NPCE) | Grant/award (A): 15,507 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Hyperfine, Inc. (HYPR) | Grant/award (A): 79,200 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | Envista Holdings Corp (NVST) | Grant/award (A): 14,170 @ $0 | EDGAR |
| 2023-09-05 | 4 | NUVASIVE INC (NUVA) | Disposition to issuer (D): 1,360 · Disposition to issuer (D): 2,577 (derivative) @ $0 · Disposition to issuer (D): 3,095 (derivative) @ $0 · Disposition to issuer (D): 2,702 (derivative) @ $0 · Disposition to issuer (D): 3,788 (derivative) @ $0 · Disposition to issuer (D): 4,816 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Acutus Medical, Inc. (AFIB) | Grant/award (A): 10,920 @ $0 · Grant/award (A): 25,480 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | NUVASIVE INC (NUVA) | Grant/award (A): 4,816 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | Hyperfine, Inc. (HYPR) | Grant/award (A): 112,000 (derivative) @ $0 · Disposition to issuer (D): 237,437 (derivative) @ $0 · Grant/award (A): 237,437 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | Envista Holdings Corp (NVST) | Grant/award (A): 7,625 @ $0 | EDGAR |
| 2022-11-01 | 4 | Hyperfine, Inc. (HYPR) | Disposition to issuer (D): 237,437 (derivative) · Grant/award (A): 237,437 (derivative) · Disposition to issuer (D): 712,312 (derivative) · Grant/award (A): 712,312 (derivative) · Disposition to issuer (D): 237,437 (derivative) · Grant/award (A): 237,437 (derivative) · +2 more | EDGAR |
| 2022-10-11 | 4 | Acutus Medical, Inc. (AFIB) | Grant/award (A): 2,520 @ $0 · Grant/award (A): 5,880 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | Acutus Medical, Inc. (AFIB) | Grant/award (A): 8,400 @ $0 · Grant/award (A): 19,600 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | Hyperfine, Inc. (HYPR) | Grant/award (A): 85,345 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | Acutus Medical, Inc. (AFIB) | Sale (S): 60,000 @ $0.58 | EDGAR |
| 2022-05-31 | 4 | Envista Holdings Corp (NVST) | Grant/award (A): 5,930 @ $0 | EDGAR |
| 2022-05-13 | 4 | NUVASIVE INC (NUVA) | Grant/award (A): 3,788 (derivative) @ $0 | EDGAR |
| 2022-03-31 | 4 | Hyperfine, Inc. (HYPR) | Grant/award (A): 237,437 (derivative) @ $0 | EDGAR |
| 2022-01-10 | 4/A | Hyperfine, Inc. (HYPR) | Grant/award (A): 19,586 @ $0 · Grant/award (A): 712,312 (derivative) · Grant/award (A): 237,437 (derivative) · Grant/award (A): 237,437 (derivative) | EDGAR |
| 2021-12-23 | 4 | Hyperfine, Inc. (HYPR) | Grant/award (A): 16,483 @ $0 · Grant/award (A): 712,312 (derivative) · Grant/award (A): 237,437 (derivative) · Grant/award (A): 237,437 (derivative) | EDGAR |
| 2021-05-27 | 4 | Envista Holdings Corp (NVST) | Grant/award (A): 5,455 @ $0 | EDGAR |
| 2021-05-20 | 4 | NUVASIVE INC (NUVA) | Grant/award (A): 2,702 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1365493 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs